John Nuss
2022
In 2022, John Nuss earned a total compensation of $1.8M as Chief Scientific Officer at Ventyx Biosciences, a 63% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $211,140 |
|---|---|
| Option Awards | $1,171,600 |
| Salary | $437,396 |
| Other | $8,454 |
| Total | $1,828,590 |
Nuss received $1.2M in option awards, accounting for 64% of the total pay in 2022.
Nuss also received $211.1K in non-equity incentive plan, $437.4K in salary and $8.5K in other compensation.
Rankings
In 2022, John Nuss' compensation ranked 1,898th out of 5,717 executives tracked by ExecPay. In other words, Nuss earned more than 66.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,898 out of 5,717 | 67th |
Division Manufacturing | 1,002 out of 3,111 | 68th |
Major group Chemicals And Allied Products | 418 out of 1,410 | 70th |
Industry group Drugs | 383 out of 1,311 | 71st |
Industry Pharmaceutical Preparations | 274 out of 957 | 71st |
Source: SEC filing on April 26, 2023.
Nuss' colleagues
We found two more compensation records of executives who worked with John Nuss at Ventyx Biosciences in 2022.